Pfizer
and IIT-Delhi on Tuesday said they have launched an incubation
accelerator initiative at the later’s campus for Indian startup
companies as well as individuals.
For innovators seeking comprehensive
support to translate their healthcare ideas into patents, the programme
will provide two years of residential incubation at IIT-Delhi, funding
of up to Rs.50 lakh for each innovator, mentoring support from
IIT-Delhi’s faculty, access to infrastructure and prototyping
laboratories, IP search and filing services, guidance from Pfizer’s
global experts, and access to venture capitalists and other industry
linkages.
For innovators who already have a ready
proof of concept and are seeking to obtain a patent, the programme will
provide access to IP attorneys and services and cover the patent fee.
The programme will invite two rounds of
proposals during 2015-2016. Call for proposals for the first round will
open from November 27 until January 15, 2016.
An independent panel of subject matter
experts will review and shortlist the potential incubates while the
Technology Business Incubator Unit board at IIT Delhi will make the
final selection of individuals and startups.